Q-linea Past Earnings Performance

Past criteria checks 0/6

Q-linea's earnings have been declining at an average annual rate of -10.8%, while the Medical Equipment industry saw earnings growing at 5.9% annually. Revenues have been growing at an average rate of 42.1% per year.

Key information

-10.8%

Earnings growth rate

3.6%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate42.1%
Return on equity-121.0%
Net Margin-4,145.4%
Next Earnings Update03 May 2024

Recent past performance updates

Recent updates

Here's Why Q-linea (STO:QLINEA) Must Use Its Cash Wisely

Dec 31
Here's Why Q-linea (STO:QLINEA) Must Use Its Cash Wisely

Will Q-linea (STO:QLINEA) Spend Its Cash Wisely?

May 07
Will Q-linea (STO:QLINEA) Spend Its Cash Wisely?

Q-linea (STO:QLINEA) Is In A Good Position To Deliver On Growth Plans

Jan 11
Q-linea (STO:QLINEA) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Q-linea (STO:QLINEA) Will Use Its Cash Wisely

Feb 17
We're Hopeful That Q-linea (STO:QLINEA) Will Use Its Cash Wisely

Do Institutions Own Q-linea AB (publ) (STO:QLINEA) Shares?

Dec 26
Do Institutions Own Q-linea AB (publ) (STO:QLINEA) Shares?

Revenue & Expenses Breakdown
Beta

How Q-linea makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:QLINEA Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 236-2292150
30 Sep 236-2392140
30 Jun 235-2492210
31 Mar 238-2572250
31 Dec 2214-2692260
30 Sep 2218-2562150
30 Jun 2216-2462080
31 Mar 2216-2412030
31 Dec 2110-2311950
30 Sep 216-2372060
30 Jun 215-2362040
31 Mar 211-2261920
31 Dec 201-2191840
30 Sep 200-2241820
30 Jun 200-2101710
31 Mar 201-1971630
31 Dec 191-1771470
30 Sep 191-1551310
30 Jun 192-1491240
31 Mar 191-1411160
31 Dec 181-1281040
30 Sep 182-111910
30 Jun 182-97790
31 Dec 172-68580
31 Dec 160-60510

Quality Earnings: QLINEA is currently unprofitable.

Growing Profit Margin: QLINEA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: QLINEA is unprofitable, and losses have increased over the past 5 years at a rate of 10.8% per year.

Accelerating Growth: Unable to compare QLINEA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: QLINEA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (27.6%).


Return on Equity

High ROE: QLINEA has a negative Return on Equity (-120.95%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.